These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 5190600)

  • 41. [Did the arrival of prostanoids modify therapeutic indications in peripheral obstructive arteriopathies? Considerations based on our experience].
    Cardia G; Tumolo R; Cuscito C
    G Chir; 1997 May; 18(5):297-300. PubMed ID: 9312259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 44. [ANTICOAGULATION ACTIVITY OF HEPARIN IN THE BLOOD OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE BLOOD VESSELS OF THE LOWER EXTREMITIES].
    DEKHTIAR AL
    Klin Med (Mosk); 1963 Jun; 41():38-43. PubMed ID: 14068990
    [No Abstract]   [Full Text] [Related]  

  • 45. Double blind trial of nialamide in intermittent claudication. Effects on blood cholesterol, fibrinolysis and 5-hydroxytryptamine.
    Tsapogas MJ; Flute PT
    Vasc Dis; 1964 Sep; 1(5):249-51. PubMed ID: 4867905
    [No Abstract]   [Full Text] [Related]  

  • 46. [Late results of treatment of circulatory disorders of the lower extremities with Mydocalm].
    Chmielewski F
    Wiad Lek; 1969 Mar; 22(6):575-80. PubMed ID: 5788875
    [No Abstract]   [Full Text] [Related]  

  • 47. [Experience with the treatment of Buerger's disease and obliterating arteriosclerosis of the lower extremities].
    ZAPLETAL B; FISCHER J; VELCL B
    Rozhl Chir; 1952; 31(3-5):127-38. PubMed ID: 13004884
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thrombolytic treatment of chronic arterial obstruction].
    Mazák J; Bláha M; Vodicková L; Pidrman V
    Vnitr Lek; 1974 Jul; 20(6):596-602. PubMed ID: 4844794
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [MAST CELLS OF THE SKIN IN ARTERIOSCLEROSIS OBLITERANS OF LOWER EXTREMITIES AND BUERGER'S DISEASE].
    WRZOLKOWA T
    Patol Pol; 1964; 15():445-50. PubMed ID: 14318883
    [No Abstract]   [Full Text] [Related]  

  • 51. Chronic occlusive arterial disease of the lower extremities.
    deWolfe VG
    Cardiovasc Clin; 1983; 13(2):15-35. PubMed ID: 6839320
    [No Abstract]   [Full Text] [Related]  

  • 52. [DIISOPROPYLAMMONIUM DICHLOROETHANOATE (DIEDI). TREATMENT OF PERIPHERAL ARTERIOPATHIES OF OLD AGE].
    MOCCHI N; MALUSARDI R
    Gazz Med Ital; 1963 Oct; 122():310-5. PubMed ID: 14095912
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic occlusive arterial disease of the extremities.
    JUERGENS JL
    Circulation; 1963 May; 27():964-9. PubMed ID: 14042045
    [No Abstract]   [Full Text] [Related]  

  • 54. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

  • 56. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanographic evaluation of peripheral hemodynamic effects of medico-surgical treatment in chronic obliterating arteriopathies].
    Warembourg H; Lekieffre J; Dupuis B; Vasseur P
    Angeiologie; 1970; 22(2):115-22. PubMed ID: 5448497
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.